Compare XLO & GRSD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | XLO | GRSD |
|---|---|---|
| Founded | 2016 | N/A |
| Country | United States | Jersey |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Services-Misc. Amusement & Recreation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 56.9M | 58.3M |
| IPO Year | 2021 | 2021 |
| Metric | XLO | GRSD |
|---|---|---|
| Price | $9.17 | $2.32 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $28.00 | N/A |
| AVG Volume (30 Days) | 23.3K | ★ 277.1K |
| Earning Date | 05-14-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $43,766,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $168.77 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 589.88 | N/A |
| 52 Week Low | $0.46 | $1.63 |
| 52 Week High | $9.89 | $2.07 |
| Indicator | XLO | GRSD |
|---|---|---|
| Relative Strength Index (RSI) | 55.69 | 74.83 |
| Support Level | $7.47 | $1.78 |
| Resistance Level | $9.22 | N/A |
| Average True Range (ATR) | 0.38 | 0.13 |
| MACD | -0.00 | 0.01 |
| Stochastic Oscillator | 54.04 | 67.42 |
Xilio Therapeutics Inc is a clinical-stage biotechnology company focused on discovering and developing masked immuno-oncology (I-O) therapies to improve outcomes for people living with cancer. Leveraging its clinically validated masking technology and capabilities, the company develops I-O therapies designed to selectively activate within the tumor microenvironment to achieve durable efficacy without the severe side effects associated with systemically active I-O agents. Its integrated biology and protein engineering approach enables the design and development of potent masked biologics that are activated by tumor-specific proteases.